Secarna Pharmaceuticals

Secarna Pharmaceuticals and Orbit Discovery enter collaboration to discover and develop peptide-conjugated targeted antisense oligonucleotide therapeutics

Partnership expands spectrum of Secarna’s capabilities for the development of targeted ASOs beyond antibodies and sugar molecules New platform capabilities extend the reach of Secarna’s antisense approaches, potentially offering new treatment options for a wider range of diseases. 28 May 2024 -- Martinsried, Germany, and Oxford, UK -- Secarna Pharmaceuticals, a leading independent European antisense...
Am Klopferspitz 19 82152 Planegg / Martinsried Germany

+49 (0) 6421/9830050